EcoDrugPlus

Glutamate Receptor 1-Like

Ensembl ID : ENSOKIG00005029474
Gene Symbol: LOC109878954
3 Cross references
246 Possible Orthologues:

Glutamate Receptor 2

Ensembl ID : ENSOKIG00005012709
Gene Symbol: LOC109905282
3 Cross references
219 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSOKIG00005006992
Gene Symbol: LOC109892910
3 Cross references
244 Possible Orthologues:

Glutamate Receptor 4-Like

Ensembl ID : ENSOKIG00005021164
Gene Symbol: LOC109873442
3 Cross references
243 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSOKIG00005036255
Gene Symbol: LOC109874355
3 Cross references
200 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSOKIG00005004383
Gene Symbol: LOC109884114
3 Cross references
151 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSOKIG00005009364
Gene Symbol: LOC109868635
3 Cross references
198 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d

Ensembl ID : ENSOKIG00005015484
Gene Symbol: LOC109904456
2 Cross references
207 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSOKIG00005040210
Gene Symbol: LOC109906927
2 Cross references
206 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 2

Ensembl ID : ENSOKIG00005019325
Gene Symbol: LOC109876212
2 Cross references
246 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3a

Ensembl ID : ENSOKIG00005021011
Gene Symbol: GRIA3A
1 Cross references
245 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSOKIG00005037615
Gene Symbol: GRIN2BB
1 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).